BBiTV
Broadband iTV designs, executes, and manages interactive television applications. Using BBiTV’s plug-and-play technology, cable operators can establish an interactive community channel on their system quickly and easily. This channel enables community members to use television in a way they never have before—to communicate among themselves, to build stronger interactions between community groups, and to buy and sell goods and services directly with one another.
BioHitech
BioHitech provides a simple, environmentally friendly, and cost-effective solution for food waste disposal. BioHiTech is using technology to open new opportunities in an industry that has gone unchanged for almost 50 years. BioHiTech offers customers a more cost-effective and technologically innovative solution compared to traditional disposal. This approach will help reduce the generation of waste as well as reduce costs and increase recycling rates. BioHitech has a global distribution license to sell, lease, use, distribute, and manufacture the product currently known as the Eco-Safe Digester. Recognizing that the traditional waste management industry has remained relatively resistant to adoption of emerging technologies and has been reluctant to provide consumers with transparency of their waste streams, BioHitech America has improved on its Eco-Safe Digester with the addition of a new, data-driven management tool (BioHitech Cloud).
Ensysce Biosciences
Ensysce Biosciences is an integrated drug delivery company with two proprietary, novel platforms for the pain and cancer markets. The Company's near term clinical program initiated in early 2016 for PF614. PF614 with BIO-MD™ technology was developed to prevent abuse of oxycodone, a pain medicine with $2.8 billion in annual sales,. Ensysce’s SWCNT technology is poised to transform delivery of large biomolecules. Ensysce's BIO-MD™ platform is a proprietary abuse-resistant opioid prodrug technology that has broad potential to address the concurrent challenges of treating patients with chronic pain while reducing prescription opioid abuse. The BIO-MD™ platform eliminates a patients’ ability to abuse prescription medicines by the non-oral route. The company’s extensive portfolio of BIO-MD™ products provides the company with numerous partnership and co-development opportunities. Ensysce has created single-walled carbon nanotubes (SWCNT) for delivery of large biomolecules. Based on the pioneering work of the late Nobel Prize winner Dr. Richard Smalley, SWCNT have the potential to provide intravenously delivered immune and gene therapies.
Liquidmetal Coatings
Liquidmetal is a revolutionary material technology discovered in conjunction with NASA. Considered one of the their top discoveries, it has the potential to fundamentally change the paradigm in material science. Liquidmetal harness this technology to produce the world’s leading wear and corrosion solutions. Liquidmetal Coatings is an industry leader in the development of amorphous alloy solutions for wear and corrosion and holds a portfolio of technology patents. The Company’s proprietary line of amorphous alloys are deployed as the top performing solutions to wear and corrosion in many industries including: Oil & Gas, Power Generation, Pulp & Paper, Mining and others, where extensive use or corrosion can cause higher maintenance costs, increased replacement costs and/or preventable downtime costs. Liquidmetal derives its revenue from its Materials, Services and Products Groups with a recurring customer base of over 100 global companies buying products and services. Many of Liquidmetal’s customers are long standing and have purchased products from Liquidmetal consistently in each of the last 10 years.
Power Analytics Global
Power Analytics Global is a global next generation energy management company that specializes in asset lifecycle extension, intellectual property development, and real-time analytics and asset management for power and industries supported by power. The Company offers a global portfolio of end-to-end energy optimization and lifecycle management solutions developed from proprietary intellectual property,
engineered systems, and operational expertise. The Power Analytics suite of world-class software gives any enterprise, government entity, or healthcare professional control over their critical data, from capturing and modeling to simulation and analysis, and as a result, saving millions of dollars, eliminating a dangerous work environment, reducing costs, protecting critical assets and improving business reliability.
engineered systems, and operational expertise. The Power Analytics suite of world-class software gives any enterprise, government entity, or healthcare professional control over their critical data, from capturing and modeling to simulation and analysis, and as a result, saving millions of dollars, eliminating a dangerous work environment, reducing costs, protecting critical assets and improving business reliability.
Precipio
Precipio Diagnostics is a fully-established, operating diagnostics company that has successfully processed over 2000 patient cases from over 60 customers. Precipio is the only diagnostics company to address the challenges of disease misdiagnosis and bring a solution to the clinical world. Precipio has successfully combined the experience, knowledge and expertise of academic-level pathology, with commercial-level service. The Company has exclusive contracts with Yale University and the University of Pennsylvania's Pathology Labs. Physicians around the world benefit from direct access to the highest quality of diagnostic support, coupled with rapid and efficient service, needed to battle cancer. Precipio offers an ethical approach that places the patient’s care first, above economic interests. Using a proprietary algorithmic approach to match disease symptoms with testing modalities, Precipio achieves a higher level of diagnostic accuracy, which benefits the patient, the physician, and maximizes return on healthcare dollars spent. Through collaborations with world-class academic institutions specializing in cancer research, diagnostics & treatment, and the Company's experience delivering quality service - Precipio offers a new standard of diagnostic accuracy, service & support, and the highest level of care to patients.
Transgenomic
Transgenomic, Inc. is a global biotechnology company advancing personalized medicine in oncology and inherited diseases through advanced diagnostic technologies, such as its revolutionary ICE COLD-PCR, which enables use of liquid biopsies for mutation detection. The company also provides specialized clinical and research services to biopharmaceutical companies developing targeted therapies. Transgenomic’s diagnostic technologies are designed to improve medical diagnoses and patient outcomes.
